TABLE 1.
Flash glucose monitoring data for the whole cohort in March and May 2020 (N = 572)
| March 2020 | May 2020 | Median difference | P comparing March 2020 and May 2020 | |
|---|---|---|---|---|
| Average glucose, mmol/l | 9.6 (8.5 to 10.9) | 9.3 (8.1 to 10.4) | –0.4 (–1.1 to 0.3) | <0.001 |
| sd glucose, mmol/l | 3.6 (3.0 to 4.3) | 3.5 (2.8 to 4.0) | –0.2 (–0.5 to 0.2) | <0.001 |
| IQR glucose, mmol/l | 5.0 (4.1 to 6.0) | 4.8 (3.9 to 5.8) | –0.2 (–0.8 to 0.4) | <0.001 |
| Coefficient of variation glucose, % | 37 (33 to 42) | 37 (33 to 42) | –0.1 (–3.2 to 2.9) | 0.420 |
| Low glucose events, number/14 days | 7 (3 to 12) | 7 (3 to 14) | 1 (–2 to 3) | 0.003 |
| Low glucose event duration, min | 90 (60 to 120) | 92 (65 to 127) | 3 (–26 to 34) | 0.061 |
| % time below target range: <3.9 mmol/l | 3 (1 to 6) | 3 (1 to 7) | 0 (–1 to 2) | 0.005 |
| % time in range: 3.9–10.0 mmol/l | 53 (41 to 64) | 56 (45 to 68) | 3 (–4 to 10) | <0.001 |
| % time above range: >10.mmol/l | 42 (29 to 56) | 39 (25 to 51) | –3 (–11 to 3) | <0.001 |
| Number of daily scans | 10 (7 to 15) | 10 (7 to 15) | 0 (–2 to 1) | 0.074 |
| % flash glucose monitoring data captured | 94 (90 to 97) | 93 (88 to 96) | –1 (–4 to 1) | <0.001 |
| Estimated HbA1c | <0.001 | |||
| mmol/mol | 61 (53 to 69) | 58 (50 to 66) | –2 (–7 to 2) | |
| % | 7.7 (7.0 to 8.5) | 7.5 (6.7 to 8.2) | –0.2 (–0.6 to 0.2) | |
| Time in range target met (>70%), n/N (%) | 93/572 (16) | 122/572 (21) | NA | 0.001 |
| Hypoglycaemia target met (<5%), n/N (%) | 365/572 (64) | 332/572 (58) | NA | 0.004 |
| Time in range and hypoglycaemia targets met, n/N (%) | 55/572 (9.6) | 65/572 (11) | NA | 0.261 |
Data are median (IQR), unless otherwise indicated.
Abbreviation: IQR, interquartile range.